Abstract：
BACKGROUND:Less than 20% of Pakistani women with early-onset or familial breast/ovarian cancer harbor germ line mutations in the high-penetrance genes BRCA1, BRCA2 and TP53. Thus, mutations in other genes confer genetic susceptibility to breast cancer, of which CHEK2 is a plausible candidate. CHEK2 encodes a checkpoint kinase, involved in response to DNA damage. METHODS:In the present study we assessed the prevalence of CHEK2 germ line mutations in 145 BRCA1/2-negative early-onset and familial breast/ovarian cancer patients from Pakistan (Group 1). Mutation analysis of the complete CHEK2 coding region was performed using denaturing high-performance liquid chromatography analysis, followed by DNA sequencing of variant fragments. RESULTS:Two potentially deleterious missense mutations, c.275C>G (p.P92R) and c.1216C>T, (p.R406C), were identified (1.4%). The c.275C>G mutation is novel and has not been described in other populations. It was detected in a 30-year-old breast cancer patient with a family history of breast and multiple other cancers. The c.1216C>T mutation was found in a 34-year-old ovarian cancer patient from a family with two breast cancer cases. Both mutations were not detected in 229 recently recruited BRCA1/2-negative high risk patients (Group 2). CONCLUSION:Our findings suggest that CHEK2 mutations may not contribute significantly to breast/ovarian cancer risk in Pakistani women.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Rashid MU,Muhammad N,Faisal S,Amin A,Hamann Udoi
10.1186/1471-2407-13-312subject
Has Abstractpub_date
2013-06-27 00:00:00pages
312issn
1471-2407pii
1471-2407-13-312journal_volume
13pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:The prevalence of patients with gastrointestinal stromal tumourgst (GIST) who fail currently available treatments imatinib and sunitinib (third-line treatment-eligible GIST) is unknown, but is expected to be below an ultra-orphan disease threshold of 2/100,000 population used in England and Wales. Our study ...
journal_title：BMC cancer
pub_type： 杂志文章,评审
doi：10.1186/1471-2407-14-364
更新日期：2014-05-24 00:00:00
abstract：BACKGROUND:Solid tumours are less oxygenated than normal tissues. This is called tumour hypoxia and leads to resistance to radiotherapy and chemotherapy. The molecular mechanisms underlying such resistance have been investigated in a range of tumour types, including the adult brain tumours glioblastoma, yet little is k...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5476-9
更新日期：2019-04-03 00:00:00
abstract：BACKGROUND:Cytochrome P450 1B1 (CYP1B1) has been shown to be up-regulated in many types of cancer including renal cell carcinoma (RCC). Several reports have shown that CYP1B1 can influence the regulation of tumor development; however, its role in RCC has not been well investigated. The aim of the present study was to d...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1951-0
更新日期：2015-12-01 00:00:00
abstract：BACKGROUND:Art therapy may improve the physical, mental, and emotional wellbeing of individuals for a variety of purposes. It remains understudied and underutilized in cancer care. We sought to determine the ability of a pilot art therapy program to improve the physical, mental, and emotional well-being of cancer patie...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07380-5
更新日期：2020-09-22 00:00:00
abstract：BACKGROUND:Metronomic chemotherapy is considered an anti-angiogenic therapy that involves chronic administration of low-dose chemotherapy at regular short intervals. We investigated the optimal metronomic dose of oral vinorelbine when given as monotherapy in patients with metastatic cancer. METHODS:Patients with recur...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1186/1471-2407-13-263
更新日期：2013-05-29 00:00:00
abstract：BACKGROUND:Endometrial cancer, one of the most common malignant tumors, is a serious threat to women's health. Endometrial hyperplasia is a precursor of endometrial cancer. S100 calcium binding protein P (S100P) has been found to play important roles in many types of cancer. The present study aimed to investigate the e...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07350-x
更新日期：2020-09-03 00:00:00
abstract：BACKGROUND:Tyrosine kinase inhibitors (TKIs) are currently approved for the treatment of metastatic renal cell carcinoma (mRCC). The cardiotoxic effects of sorafenib and sunitinib may cause hypertension, left ventricular ejection fraction (LVEF) dysfunction and/or congestive heart failure (CHF), and arterial thrombo-em...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-231
更新日期：2012-06-11 00:00:00
abstract：BACKGROUND:The numerous side effects of chemotherapy in patients with breast cancer are well known. However, the precise effects of chemotherapy on ovarian function in premenopausal women are poorly investigated. The patients are at risk of developing sexual hormone deficiency and impaired fertility. This prospective c...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3593-x
更新日期：2017-09-06 00:00:00
abstract：BACKGROUND:Natural killer (NK) cell dysfunction following cancer surgery has been shown to promote metastases. Recent studies demonstrate an emerging role for lipids in the modulation of NK cell innate responses. However, the mechanisms involved in lipid modulation of NK cell postoperative anti-tumor function are unkno...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6045-y
更新日期：2019-08-20 00:00:00
abstract：BACKGROUND:In Australia, associations between geographic remoteness, socioeconomic disadvantage, and colorectal cancer (CRC) survival show that survival rates are lowest among residents of geographically remote regions and those living in disadvantaged areas. At present we know very little about the reasons for these i...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-24
更新日期：2010-01-28 00:00:00
abstract：BACKGROUND:Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancers, and is the leading cause of cancer deaths. Radiation therapy (RT), alone or in combination with chemotherapy, is the standard of care for curative intent treatment of patients with locally advanced or inoperable NSCLC. The ability to intens...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章
doi：10.1186/1471-2407-14-740
更新日期：2014-10-02 00:00:00
abstract：BACKGROUND:Genetics-based basket trials have emerged to test targeted therapeutics across multiple cancer types. However, while vemurafenib is FDA-approved for BRAF-V600E melanomas, the non-melanoma basket trial was unsuccessful, suggesting mutation status is insufficient to predict response. We hypothesized that prote...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6175-2
更新日期：2019-10-31 00:00:00
abstract：BACKGROUND:Intrahepatic cholangiocarcinomas are malignant tumors arising from the intrahepatic biliary tract. The pathogenesis of these tumors remains unknown. Although there is a marked global variation in prevalence, some recent studies have suggested an increase in mortality from intrahepatic cholangiocarcinoma in s...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-2-10
更新日期：2002-05-03 00:00:00
abstract：BACKGROUND:Given their frequency of occurrence in the United States, cancer and heart disease often coexist. For patients requiring open-heart surgery, this raises concern that the use of cardiopulmonary bypass (CPB) may cause a transient immunosuppression with the potential to promote the spread and growth of coexisti...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-519
更新日期：2013-11-03 00:00:00
abstract：BACKGROUND:Toll-like receptor 3 (TLR3) is a critical component of the innate immune response to dsRNA viruses, which was considered to be mainly expressed in immune cells and some endothelial cells. In this study, we investigated the expression and proapoptotic activity of TLR3 in human and murine tumor cell lines. ME...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-12
更新日期：2008-01-17 00:00:00
abstract：BACKGROUND:Triple-negative breast cancer (TNBC) is a type of breast cancer with a high degree of malignancy. Because of the remarkable biological characteristics of high invasion, metastasis and recurrence, TNBC is often accompanied by a poor prognosis. As a molecular characteristic of TNBC, high expression of CD147 ha...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5796-9
更新日期：2019-06-13 00:00:00
abstract：BACKGROUND:Accurate staging of colorectal cancer (CRC) with clinicopathological parameters is important for predicting prognosis and guiding treatment but provides no information about organ site of metastases. Patterns of genomic aberrations in primary colorectal tumors may reveal a chromosomal signature for organ spe...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-662
更新日期：2010-12-02 00:00:00
abstract：BACKGROUND:Double stranded RNA (dsRNA) has multiple anti-tumor mechanisms. Over the past several decades, there have been numerous attempts to utilize synthetic dsRNA to control tumor growth in animal models and clinical trials. Recently, it became clear that intracellular dsRNA is more effective than extracellular dsR...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-110
更新日期：2011-03-28 00:00:00
abstract：BACKGROUND:Recurrence of colorectal cancer (CRC) may arise due to the persistence of drug-resistant and cancer-initiating cells that survive exposure to chemotherapy. Proteins responsible for this recurrence include the chemokine receptor CXCR4, which is known to enable CRC metastasis, as well as the cancer-initiating ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1702-2
更新日期：2015-11-10 00:00:00
abstract：BACKGROUND:The scientific and public debate concerning organized mammography screening is unprecedentedly strong. With research evidence concerning its efficacy being ambiguous, the recommendations pertaining to the age-thresholds for program inclusion vary between - and even within - countries. Data shows that young w...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3180-1
更新日期：2017-03-21 00:00:00
abstract：BACKGROUND:The bone scan index (BSI) using a computer-aided diagnosis system for bone scans is expected to be an objective and quantitative clinical tool for evaluating bone metastatic prostate cancer. This study aimed to evaluate the pretreatment BSI as a prognostic factor in hormone-naive prostate cancer patients wit...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2176-6
更新日期：2016-02-19 00:00:00
abstract：BACKGROUND:This study aimed to evaluate the long-term outcome and toxicities in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by concurrent chemoradiotherapy (CCRT) with/without adding cetuximab. METHODS:A total of 62 patients treated with CCRT plus cetuximab were matched with 124 patien...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3552-6
更新日期：2017-08-24 00:00:00
abstract：BACKGROUND:This study aimed to evaluate the short- and long-term outcomes after laparoscopic resection for low rectal cancer (LRC) compared with mid/high rectal cancer (M/HRC). METHODS:Patients with rectal cancer undergoing laparoscopic resection with curative intent were retrospectively reviewed between 2009 and 2015...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07255-9
更新日期：2020-08-14 00:00:00
abstract：BACKGROUND:Estrogen receptor positive breast cancers have high recurrence rates despite tamoxifen therapy. Breast cancer stem/progenitor cells (BCSCs) initiate tumors, but expression of estrogen (ER) or progesterone receptors (PR) and response to tamoxifen is unknown. Interleukin-6 (IL-6) and interleukin-8 (IL-8) may i...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-733
更新日期：2014-09-30 00:00:00
abstract：BACKGROUND:Bevacizumab, an antibody neutralizing Vascular Endothelial Growth Factor (VEGF), is licensed for the management of patients with advanced colon cancer. However, tumor biomarkers identifying the molecular tumor subsets most amenable to angiogenesis modulation are lacking. METHODS:We profiled expession of 245...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究
doi：10.1186/1471-2407-14-111
更新日期：2014-02-20 00:00:00
abstract：BACKGROUND:Treatment of locally advanced non-small-cell lung cancer is based on a combined approach. To study the impact of trimodal therapy for stage III-N2 NSCLC a single centre retrospective evaluation focusing on survival and therapy-related toxicity was performed. METHODS:71 patients diagnosed between March 2001 ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-572
更新日期：2014-08-07 00:00:00
abstract：BACKGROUND:The literature on sexual orientation disclosure is arguably one of the most developed in the field of lesbian, gay and bisexual (LGB) people in healthcare in English speaking countries however, relatively little research has been conducted into disclosure in cancer care. Studies have been mainly undertaken i...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5895-7
更新日期：2019-07-10 00:00:00
abstract：BACKGROUND:This study aimed to determine the efficacy and complications of intravitreal chemotherapy-assisted endoresection for refractory International Classification of Retinoblastoma (ICRB) group D retinoblastoma in monocular patients. METHODS:In this retrospective case series, intravitreal chemotherapy-assisted en...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07314-1
更新日期：2020-08-26 00:00:00
abstract：BACKGROUND:The care itinerary for cancer involves difficulties that occur in several different areas, whether in the diagnostic procedures, in surgery, or in adjuvant treatment. The aim of this work was to obtain a valid instrument measuring satisfaction among patients with breast cancer and exploring their care itiner...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-7-129
更新日期：2007-07-16 00:00:00
abstract：BACKGROUND:There is no consensus on the therapeutic approach to ECOG 2 patients with locally advanced non-small-cell lung cancer (LA-NSCLC), despite the sizable percentage of these patients in clinical practice. This study focused on the efficacy, toxicity and the optimal chemotherapy regimen of CCRT in ECOG 2 patients...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-06780-x
更新日期：2020-04-06 00:00:00
